The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 03, 2005

Filed:

Aug. 04, 1999
Applicants:

Tomokazu Nagano, Osaka-shi, Osaka 554-0022, JP;

Ikue Kudo, Tokyo 101-8319, JP;

Takao Kawamura, Osaka-shi, Osaka 554-0022, JP;

Mutsuo Taiji, Osaka-shi, Osaka 554-0022, JP;

Hiroshi Noguchi, Tokyo 101-8319, JP;

Shunsuke Tani, Osaka-shi, Osaka 541-8510, JP;

Hiroo Maeda, Ibaraki-shi, Osaka 567-0878, JP;

Inventors:

Tomokazu Nagano, Osaka-shi, Osaka 554-0022, JP;

Ikue Kudo, Tokyo 101-8319, JP;

Takao Kawamura, Osaka-shi, Osaka 554-0022, JP;

Mutsuo Taiji, Osaka-shi, Osaka 554-0022, JP;

Hiroshi Noguchi, Tokyo 101-8319, JP;

Shunsuke Tani, Osaka-shi, Osaka 541-8510, JP;

Hiroo Maeda, Ibaraki-shi, Osaka 567-0878, JP;

Assignee:

Other;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K038/00 ; A61K038/18 ; C07K014/00 ;
U.S. Cl.
CPC ...
Abstract

Preparations to be administered for treating or preventing ischemic diseases or arterial diseases which contain Hepatocyte growth factor (HGF) as an active ingredient. The preparations provide such effect that HGF concentration in an affected region to which HGF was administered is maintained, a half-life is longer, a dose can be reduced, and other organs except the affected region are less affected in comparison with intravenous administration.


Find Patent Forward Citations

Loading…